The Epoch Times
The Epoch Times
Focus

Oxford Vaccine

UK News
UK News
|
David English

Oxford CCP Virus Vaccine Efficacy Needs Further Evaluation: Study

Dec 10, 2020
|
David English
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
Oxford CCP Virus Vaccine Efficacy Needs Further Evaluation: Study
Dec 10
|
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
UK News
UK News
|
Mary Clark

Pfizer/BioNTech Vaccine First to Get Approval for Roll-Out in UK

Dec 02, 2020
|
Mary Clark
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
Pfizer/BioNTech Vaccine First to Get Approval for Roll-Out in UK
Dec 02
|
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
UK News
UK News
|
Simon Veazey

Oxford Vaccine Triggers ‘Robust’ Immune Response in Older People

Nov 19, 2020
|
Simon Veazey
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
Oxford Vaccine Triggers ‘Robust’ Immune Response in Older People
Nov 19
|
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
UK News
UK News
|
David English

Oxford CCP Virus Vaccine Efficacy Needs Further Evaluation: Study

Dec 10, 2020
|
David English
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
Oxford CCP Virus Vaccine Efficacy Needs Further Evaluation: Study
Dec 10
|
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
UK News
UK News
|
Mary Clark

Pfizer/BioNTech Vaccine First to Get Approval for Roll-Out in UK

Dec 02, 2020
|
Mary Clark
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
Pfizer/BioNTech Vaccine First to Get Approval for Roll-Out in UK
Dec 02
|
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
UK News
UK News
|
Simon Veazey

Oxford Vaccine Triggers ‘Robust’ Immune Response in Older People

Nov 19, 2020
|
Simon Veazey
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
Oxford Vaccine Triggers ‘Robust’ Immune Response in Older People
Nov 19
|
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
home-iconepochtv-iconhealth-iconbright-iconepochfun-icon
The Epoch Times
To ensure we reach the high standards of reliability and neutrality that you expect from us, we are engaging with Ad Fontes Media to analyze our content. If you find an article you think falls short of the standard, please submit the link through this form.
Copyright © 2000 - 2025 The Epoch Times Association Inc. All Rights Reserved.